Molecular diagnostic services and research and development for pharmaceutical and biotechnology industries.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: April 2026
This analysis is not yet available in English. Please see the French version.
Leading organizations
bioMérieux
A
Development and provision of in vitro diagnostic solutions for infectious diseases, microbiology, immunoassays, and industrial product safety.
Sebia
B
Development and marketing of specialized in vitro diagnostic solutions for various pathologies, including oncological, metabolic, genetic, autoimmune, and infectious diseases.
Novalix
B
Drug discovery services for biotech and pharmaceutical companies, including chemistry, biophysics, pharmacology, and DMPK.
Initiatives identified among leaders
Développement d'une offre commerciale pour lutter contre l'antibiorésistance
“bioMérieux développe une offre commerciale pour lu...” - bioMérieuxAméliorer notre engagement social et sociétal
“Sebia considère l’ensemble de ses collaborateurs c...” - SebiaObjectif de réduction des émissions de gaz à effet de serre
“bioMérieux s'engage à réduire les émissions de gaz...” - bioMérieux46% of similar organizations communicate on CSR issues
+1146 initiatives collected from 50 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports